Click here to subscribe

StockInvest.us provides financial data and technical analysis on stocks. Usage of our website will not be held liable for any losses in your investments accounts based on any information provided on the website. All users should speak with their financial adviser before buying or selling any securities. Users should not base their investment decision upon StockInvest.us to make an investment decision. By accessing the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read full disclaimer here.


When you've been approved for margin stock trading, you're also eligible to short stock. Almost every successful stock trader has shorted stock at one time or another. When you short stock, you make money when the company's shares fall—or, even better yet, when they crash. The problem is that you can expose yourself to unlimited liability when you do this. 
Getting “early access” to options or Web is defined as signing up with a valid email address for a spot in Robinhood Financial’s respective waitlist queues for Web or for options. Getting “early access” to Robinhood Crypto is defined as signing up with a valid email address for a spot in Robinhood Crypto’s waitlist queue. Early access to the waitlist for Web, options, or Robinhood Crypto should in no way be construed as confirmation that a brokerage account with Robinhood Financial has been opened or will even be approved for opening. Priority may be given to Robinhood Gold subscribers and existing customers of Robinhood Financial.
A mentor could be a family member, a friend, a past or current professor, co-worker, or any individual that has a fundamental understanding of the stock market. A good mentor is willing to answer questions, provide help, recommend useful resources, and keep spirits up when the market gets tough. All successful investors of the past and present have had mentors during their early days.

uniQure N.V. (QURE) jumped $6.10, or 9.4%, to $70.74 on 2.5 million shares Tuesday.  The move, on nearly 5x the stock's average volume, came on no news from the gene therapy company.  The stock, which had a steep ascent from around $28 to just under $70 in the first three months of the year, looks poised to resume the uptrend, as Tuesday's move broke it out above the March double-top.  Watch for $80-85 next.
Common Stocks – When you invest in stock, you acquire an ownership stake in an actual operating business, along with your share of the net earnings and resulting dividends produced by the firm. Although you don't have to invest in stock to get rich, over the past could of centuries, equities (stocks) have been the highest returning asset class and have produced the most wealth. To learn more, read What Is Stock? which will break down the fundamentals.

This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Hong Kong, Japan, Saudi Arabia, Singapore, UK, and the countries of the European Union.
Although ETFs are designed to provide investment results that generally correspond to the performance of their respective underlying indices, they may not be able to exactly replicate the performance of the indices because of expenses and other factors. A prospectus contains this and other information about the ETF and should be read carefully before investing. Customers should obtain prospectuses from issuers and/or their third party agents who distribute and make prospectuses available for review. ETFs are required to distribute portfolio gains to shareholders at year end. These gains may be generated by portfolio rebalancing or the need to meet diversification requirements. ETF trading will also generate tax consequences. Additional regulatory guidance on Exchange Traded Products can be found by clicking here.
The nine-year-old bull market in U.S. stocks has been dominated by growth and momentum plays, such as the popular FAANG group of stocks. These momentum stocks have significantly outperformed value stocks, and Oppenheimer analyst Ari Wald says there’s no reason for investors to be fearful of momentum stocks just because stock prices are near all-time highs. After nine years, a certain degree of caution is understandable, but Wald says price action has remained bullish. Wald and the Oppenheimer analyst team recently selected the best momentum stock to buy in each of nine different market sectors.